BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pharmacogenetics
,
Doxorubicin
,
rs4950928
,
GATA1
,
G-protein-coupled receptor binding
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
MBC
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Olfactory bulb
Appendix
Superior cervical ganglion
Substantia nigra
Corpus callosum
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Combinatorial genetics reveals the Dock1-Rac2 axis as a potential target for the treatment of NPM1;C…
Impaired cell death and mammary gland involution in the absence of Dock1 and Rac1 signaling.
The Rac-specific exchange factors Dock1 and Dock5 are dispensable for the establishment of the glome…
TLR4 activation induces inflammatory vascular permeability via Dock1 targeting and NOX4 upregulation…
Phosphatidic acid-dependent recruitment and function of the Rac activator DOCK1 during dorsal ruffle…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
RWD Study in HER2+ mBC Patients in Third-Line Therapy
A Trial of MBC-11 in Patients With CIBD
STAR Cape+BKM120 MBC With Brain Met
Detection and Analysis of MBC With Heterogeneous ER Expression
500mg Fulvestrant Versus Exemestane in MBC
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ